Chromosomal aberrations after induced pluripotent stem cells reprogramming

Chromosomal aberrations after induced pluripotent stem cells reprogramming

Abstract Induced pluripotent stem cells (iPSCs) are generated from adult cells that have been reprogrammed to pluripotency. However, in vitro cultivation and genetic reprogramming increase genetic instability, which could result in chromosomal abnormalities. Maintenance of genetic stability after re...

Full description

Bibliographic Details
Main Authors:	Isadora May Vaz, Tamara Borgonovo, Tais Hanae Kasai-Brunswick, Danúbia Silva dos Santos, Fernanda Cristina Paccola Mesquita, Juliana Ferreira Vasques, Fernanda Gubert, Carmen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Paulo Roberto Slud Brofman
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Genética 2021-09-01
Series:	Genetics and Molecular Biology
Subjects:	Genetic instability cytogenetics iPSC chromosomal aberration
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572021000400103&tlng=en

Similar Items

Genetic evaluation of mesenchymal stem cells by G-banded karyotyping in a Cell Technology Center
by: Tamara Borgonovo, et al.
Published: (2014-06-01)

A PIANO (Proper, Insufficient, Aberrant, and NO Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming
by: Kejin Hu
Published: (2020-05-01)

iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
by: Eline Simons, et al.
Published: (2023-01-01)

LIF-activated Jak signaling determines Esrrb expression during late-stage reprogramming
by: Delun Huang, et al.
Published: (2018-01-01)

Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
by: Jin-he Jiang, et al.
Published: (2024-01-01)

Hierarchical Oct4 Binding in Concert with Primed Epigenetic Rearrangements during Somatic Cell Reprogramming
by: Jun Chen, et al.
Published: (2016-02-01)

Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues
by: Quentin Alle, et al.
Published: (2021-04-01)

A mitochondrial strategy for safeguarding the reprogrammed genome
by: Alessandro Prigione, et al.
Published: (2014-01-01)

Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
by: Suman C. Nath, et al.
Published: (2023-11-01)

Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors
by: A. B. Carvalho, et al.
Published: (2022-12-01)

YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
by: Giorgia Di Benedetto, et al.
Published: (2021-03-01)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
by: Omer Hatim, et al.
Published: (2023-12-01)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01)

Pattern of Chromosomal Aberrations in Patients from North East Iran
by: Saeedeh Ghazaey, et al.
Published: (2013-01-01)

Hypoxia as a Driving Force of Pluripotent Stem Cell Reprogramming and Differentiation to Endothelial Cells
by: Paulina Podkalicka, et al.
Published: (2020-11-01)

Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS
by: Ernesto Manzo, et al.
Published: (2019-06-01)

Choline Ameliorates Disease Phenotypes in Human iPSC Models of Rett Syndrome
by: Chin, Eunice W. M., et al.
Published: (2016)

Particulate matter from car exhaust alters function of human iPSC-derived microglia
by: Henna Jäntti, et al.
Published: (2024-02-01)

Dysregulated Cell Homeostasis and miRNAs in Human iPSC-Derived Cardiomyocytes from a Propionic Acidemia Patient with Cardiomyopathy
by: Mar Álvarez, et al.
Published: (2023-01-01)

Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts
by: Jin Seok Bang, et al.
Published: (2018-03-01)

mTOR, autophagy and reprogramming
by: Bor Luen eTang
Published: (2014-01-01)

Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context
by: P. Segges, et al.
Published: (2016-04-01)

JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process
by: Ling Wang, et al.
Published: (2018-03-01)

Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic Acidemia
by: Esmeralda Alonso-Barroso, et al.
Published: (2021-01-01)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
by: Francis Grafton, et al.
Published: (2021-08-01)

CtIP-Specific Roles during Cell Reprogramming Have Long-Term Consequences in the Survival and Fitness of Induced Pluripotent Stem Cells
by: Daniel Gómez-Cabello, et al.
Published: (2017-02-01)

Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
by: Sherida de Leeuw, et al.
Published: (2019-07-01)

The Role of Cytogenetic Methods in the Diagnosis of Haematological Diseases
by: Amina Aščerić, et al.
Published: (2021-06-01)

Comparison of two protocols for the generation of iPSC-derived human astrocytes
by: Patrycja Mulica, et al.
Published: (2023-09-01)

Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
by: Gladys Telliam, et al.
Published: (2023-05-01)

A New Induction Method for the Controlled Differentiation of Human-Induced Pluripotent Stem Cells Using Frozen Sections
by: Susumu Tadokoro, et al.
Published: (2021-10-01)

Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies
by: Ishnoor Sidhu, et al.
Published: (2021-10-01)

Podocytes derived from human induced pluripotent stem cells: characterization, comparison, and modeling of diabetic kidney disease
by: Julie Bejoy, et al.
Published: (2022-07-01)

Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene
by: Huifang Zhao, et al.
Published: (2020-07-01)

Integrative Meta-Analysis during Induced Pluripotent Stem Cell Reprogramming Reveals Conserved Networks and Chromatin Accessibility Signatures in Human and Mouse
by: Chloe S. Thangavelu, et al.
Published: (2023-11-01)

Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons
by: Yu Tang, et al.
Published: (2017-11-01)

Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
by: Takeshi Tokuyama, et al.
Published: (2021-09-01)

Pluripotent Stem Cells for Spinal Cord Injury Repair
by: Maria Martin-Lopez, et al.
Published: (2021-11-01)

Using human pluripotent stem cell models to study autism in the era of big data
by: Ralda Nehme, et al.
Published: (2020-03-01)

Chromosomal aberrations in multiple myeloma: A study on Indian population
by: Angel Beula P. Royal, et al.
Published: (2018-01-01)